Ani Pharmaceuticals reported $30.21M in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Aerie Pharmaceuticals AERI:US $ 29.57M 6.52M
Aurora Cannabis Inc ACB:CN -52930000 16.56M
Canopy Growth Corp WEED:CN C$ -1392000 157.85M
Depomed DEPO:US $ 30.6M 2.14M
Eli Lilly And LLY:US $ 5057.5M 680.4M
Emergent Biosolutions EBS:US $ 72.9M 78.7M
Endo International Ordinary Shares ENDP:US $ 472.5M 94.46M
Heron Therapeutics HRTX:US $ 12.1M 2.39M
Hikma Pharmaceutical HIK:LN 623M 62M
Knight Therapeutics Inc GUD:CN C$ 32.48M 4.28M
Lannett LCI:US $ 3.08M 2.63M
Nektar Therapeutics NKTR:US $ 16.47M 3.04M
Novartis NVS:US $ 9336M 277M
Perrigo Ordinary Shares PRGO:US $ 337.8M 24.6M
Sun Pharmaceuticals SUNP:IN IR 78615.6M 9544.3M
Teva Pharmaceutical TEVA:IT 1.83B 26M
Teva Pharmaceutical Industries TEVA:US $ 1828M 26M